Sangamo BioSciences | SGMO - Market Capitalization


Sangamo BioSciences reported $15.2M in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 7M 2M Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Alterity Therapeutics Limited AUD 47M 9M Jul/2026
Amgen USD 189.89B 13.64B Mar/2026
Bayer EUR 38.69B 2.33B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.86B 553M Mar/2026
Cipla INR 988.89B 231.9B Mar/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 573.66M 46.63M Jul/2026
CSL USD 55.89B 20.42B Dec/2025
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Karyopharm Therapeutics USD 1.12B 989M Jul/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Tectonic Therapeutic USD 510M 70M Jul/2026
Ultragenyx Pharmaceutical USD 2.06B 159M Mar/2026
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026